^
BIOMARKER:

JAK2 amplification

i
Other names: JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Entrez ID:
JAK2 amplification
NSCLC
nivolumab
Resistant: C3 – Early Trials
JAK2 amplification
AML
ruxolitinib
Sensitive: D – Preclinical